top of page

Interview with CEO Michelle Teng in Inside Precision Medicine

Etcembly co-founder Michelle Teng talks to Helen Albert about her journey in science and how we're building the next generation of AI-designed TCR immunotherapies.




Etcembly CEO and co-founder Michelle Teng

19 views
bottom of page